Rising Occurrence of Cervical Cancer Intensifies HPV Testing Market

HPV here stands for human papilloma virus. It is a group of viruses that attack human body, set of particular cells that are moist surfaces. Increasing prevalence of cervical cancer among women is expected to boost the HPV testing market.

Price Slash Strengthens HPV Testing Market

Due to increasing incidences of cervical cancer in women and number of deaths, the government across the globe is taking measures to reduce the HPV testing costs, especially in underdeveloped economies. The government aims at reducing the mortality rate, pushing the global HPV testing market to grow in the future.

Get Sample Copy of this Report @ 


• Rising awareness about the early diagnosis of the disease among women is expected to fuel the HPV testing market.

• North America dominates the global HPV testing market due to the growing incidences of women with cervical cancer.

• Tests kits with HPV assays provide more accuracy in the diagnosis, aiding in the expansion of the HPV testing market. Additionally, these kits are easy to use and come with directions to use them in an effective manner.

Read Comprehensive Overview of Report @


Nucleic Acid Technology Propels Growth in Global HPV Testing Market

Australia is going one step forward in cervical cancer preventive screening from cervical cytological testing to molecular nucleic acid technology (NAT) with the help of HPV DNA assays for primary cervical cancer screening. This test ensures highest degree of quality and reduces the chances of false positives or negative screening. Thus HPV NAT test is proving to be a boon to the cancer detection area in the medical sector. This technology has been welcomed and embraced by many clinicians and medical communities across the globe. More countries are adopting HPV NAT test as a method of secondary prevention for cervical cancer among women, owing to the robust expansion of the global HPV testing market in the coming years.

HPV Testing Market Supported by Growing Awareness

San Francisco, California, August 30, 2017: TMR Researches announces the addition of a new report in its expanding portfolio of pharmaceutical industry reports. It examines the global scenario of the HPV testing market, and provides the readers with a comprehensive overview of the course of the market and its components. The report is titled as ‘HPV Testing Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.’

The human papilloma virus, or HPV, alludes to a collective association of more than a hundred and fifty viruses, which induce negative changes inside a human body. They are known to cause warts or papillomas, which are a type of non-harmful tumor. In the meantime, some sorts of HPV are significantly more genuine as they have been connected to cancerous growths, particularly of the cervix. The high-hazard genital HPV’s are known to cause tumor in both genders men. They create conditions on a cellular plane which can prompt pre-cancers, followed by tumors. HPV has no key side effects to recognize its existence, except for particular kind of warts caused by a few types of the virus.

The rising pervasiveness of cervical and vaginal cancers is the primary factor driving the worldwide HPV testing market. The Centers for Disease Control and Prevention expresses that consistently 16 out of each 100,000 females are probably going to be identified with cervical tumor. Universally, it is recognized as the third-most common disease and the death rate on account of this is high. HPV test helps in the screening and early identification of cervical disease.

Governments are progressively proposing programs that are leading to awareness in regards to cervical cancer screening tests, which thus is giving a noteworthy push to the HPV testing market. Other than awareness drives, governments are additionally emptying reserves into the innovative work of screening devices, which is working wonders for the progress of the market.

Notwithstanding the activities and funds, the consistently changing administrative rules for cervical tumor screening are hampering market growth and opportunities. In addition, the absence of efficient insurance situation in a various nations is constraining the market from utilizing its potential. Then again, innovative progressions in technology are acting as an impetus for market growth.

Market participants are expected to fund research and development activities for the search of efficient tools for screening devices and kits. Some of the key players mentioned in the report are CytoCore Inc., Abbott Laboratories, Diamex GmBH, Qiagen Inc., Merk & Co., and bioMerieux SA.

Click on the link below to request a sample copy of the report